Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 3

Research Article

Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study

Table 3

Sample of patients with depression subdivided according to antidepressants.

PatientsAntidepressant1
AnyNSMRISSRIMAOIHyp.-perf.Other2
[ (%)][ (%)][ (%)][ (%)][ (%)][ (%)]

Gender
 Male555202 (36.4)53
(9.5)
34
(6.1)
1
(0.2)
124
(22.3)
26
(4.7)
 Female1889631 (33.4)182
(9.6)
106
(5.6)
3
(0.2)
415
(22.0)
59
(3.1)
Age [years]
 <40656182 (27.7)27
(4.1)
23
(3.5)
147
(22.4)
9
(1.4)
 40–591218398 (32.7)109
(8.9)
73
(6.0)
2
(0.2)
260
(21.3)
41
(3.4)
60570253 (44.4)99
(17.4)
44
(7.7)
2
(0.4)
132
(23.2)
35
(6.1)
Physician specialization
 GP1793522 (29.1)124
(6.9)
83
(4.6)
2
(0.1)
355
(19.8)
44
(2.5)
 Internist437148 (33.9)27
(6.2)
26
(5.9)
1
(0.2)
110
(25.2)
6
(1.4)
 Neurology214 163 (76.2)84
(39.3)
31
(14.5)
1
(0.5)
74
(34.6)
35
(16.4)
Type of depression
 Depressive episode2158762 (35.3)219 (10.1)120
(5.6)
4
(0.2)
497
(23.0)
78
(3.6)
 Recurrent depressive disorder28671
(24.8)
16
(5.6)
20
(7.0)
42
(14.7)
7
(2.4)
Multi-comorbidity
 No2240737 (32.9)202
(9.0)
122
(5.4)
3
(0.1)
492
(22.0)
69
(3.1)
 Yes20496
(47.1)
33
(16.2)
18
(8.8)
1
(0.5)
47
(23.0)
16
(7.8)
Comorbidity
 Coronary heart disease20284
(41.6)
27
(13.4)
17
(8.4)
1
(0.5)
48
(23.8)
9
(4.5)
 Cerebrovascular disease9956
(56.6)
27
(27.3)
13
(13.1)
23
(23.2)
12
(12.1)
 Diabetes mellitus17482
(47.1)
23
(13.2)
15
(8.6)
1
(0.6)
46
(26.4)
10
(5.7)
 Cancer351108 (30.8)27
(7.7)
17
(4.8)
1
(0.3)
70
(19.9)
12
(3.4)
 Congestive heart failure11359
(52.2)
22
(19.5)
11
(9.7)
1
(0.9)
30
(26.5)
6
(5.3)
 Chronic obstructive pulmonary disease6834
(50.0)
11
(16.2)
3
(4.4)
1
(1.5)
19
(27.9)
8
(11.8)

Total2444833 (34.1)235 (9.6)140 (5.7)4 (0.2)539 (22.1)85 (3.5)

1Double entries possible, 2including bupropion, mirtazapine, and nefazodone.
MAOIs: non-selective monoamine oxidase A inhibitors.
NSMRI: non-selective monoamine reuptake inhibitors.
SSRIs: selective serotonin reuptake inhibitors.
Others: for example, bupropion, mirtazapine, and nefazodone.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.